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Abstract
Background: H-Ras pre-mRNA undergoes an alternative splicing process to render two proteins, namely p21 H-Ras and p19
H-Ras, due to either the exclusion or inclusion of the alternative intron D exon (IDX), respectively. p68 RNA helicase (p68) is
known to reduce IDX inclusion.
Principal Findings: Here we show that p68 unwinds the stem-loop IDX-rasISS1 structure and prevents binding of hnRNP H
to IDX-rasISS1. We also found that p68 alters the dynamic localization of SC35, a splicing factor that promotes IDX inclusion.
The knockdown of hnRNP A1, FUS/TLS and hnRNP H resulted in upregulation of the expression of the gene encoding the
SC35-binding protein, SFRS2IP. Finally, FUS/TLS was observed to upregulate p19 expression and to stimulate IDX inclusion,
and in vivo RNAi-mediated depletion of hnRNP H decreased p19 H-Ras abundance.
Significance: Taken together, p68 is shown to be an essential player in the regulation of H-Ras expression as well as in a vital
transduction signal pathway tied to cell proliferation and many cancer processes.
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Introduction
H-,K-and N-Rasproteins playa significant role in controlling cell
growth, a central component of mitogenic signal transduction
pathways, reviewed in [1,2]. So far, H-ras knockout (KO) mice were
found to be viable, indicating that H-ras is not required for
embryogenesis [3]. However, H-ras mutations were shown to be an
important hallmarkinCostellosyndrome, an extremelyraredisorder
that affects multiple organ systems [4,5]. H-Ras pre-mRNA
undergoes an alternative splicing process to render two proteins,
namelyp21 H-Ras and p19 H-Ras,a processdriven by the exclusion
or inclusion of the alternative intron D exon (IDX), respectively
[6,7,8]. Due to the presence of an in-frame stop codon within IDX,
p19 mRNA is translated into a shorter protein, named p19 H-
RasIDX or p19 [7]. P19 is ubiquitous and conserved in all
mammalian species, where it localizes in the nucleus and cytosol.
Interestingly, unlike p21, p19 does not bind to GTP, thereby
indicating that these two Ras proteins have distinct and comple-
mentaryroles.P19 isalsoknownto bind toRACK1[7],ascaffolding
protein that brings together different factors, enabling them to act in
a common pathway, e.g. mitogen-activated protein kinase pathways
[9,10]. Moreover, interaction between p19 and p73b was shown to
decrease the MDM2-mediated transcriptional repression of p73b
[11]. Finally, recent studies have indicated that p19 regulates G1/S
cell cycle progression (Camats et al. unpublished).
Previously, we have characterized the cis-acting sequences and
trans-splicing factors involved in the regulation of IDX inclusion to
enable its study both in vitro and in vivo [8]. As previously shown, an
intronic silencer sequence (named rasISS1) located downstream of
IDX (see Figure 1A and 1B) negatively regulates upstream intron
splicing [8]. This inhibitory effect was observed to be partially
mediated by the binding of hnRNP A1, an inhibitor of IDX
inclusion. The SR proteins SC35 and SRp40 are known to
antagonize the negative action of hnRNP A1 stimulating IDX
inclusion [8]. Additionally, hnRNP H, FUS/TLS and the p68
RNA helicase (p68) are also associated with both IDX and rasISS1
RNA, suggesting a role for these proteins as bridging factors
between IDX and rasISS1. A stem-loop structure within the IDX-
rasISS1 sequence (see Figure 1B and 1C) was suggested to have a
regulatory role in this IDX inclusion/exclusion, a notion which is
reinforced by the observation that the knockdown of p68 increases
IDX inclusion in endogenous p19 mRNA. In this work, we have
further characterized the role of p68 in p19 regulation. Using
winding/unwinding assays, we analyzed how p68 affects IDX-
rasISS1 stem-loop structure and the binding of hnRNP H and
FUS/TLS to this IDX-rasISS1 region. RNAi-mediated depletion
experiments showed how hnRNP A1, FUS/TLS, hnRNP H and
p68 alter the activity and dynamic localization of SC35 and H-ras
alternative splicing. Here we present an updated and extended
version of the alternative splicing model for H-Ras regulation with
PLoS ONE | www.plosone.org 1 August 2008 | Volume 3 | Issue 8 | e2926Figure 1. Recently proposed model for the regulation of alternative splicing for H-Ras pre-mRNA by Guil et al. [8]. A) RasISS1 (blue
brackets) is the silencer downstream of the alternative intron D exon (IDX), showed as an yellow exon. Arrow-headed lines indicate protein-RNA
interactions. Red factors activate IDX inclusion (SC35 and SRp40); blue factors inhibit IDX inclusion. Concerning to the green factors, only direct/
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PLoS ONE | www.plosone.org 2 August 2008 | Volume 3 | Issue 8 | e2926special emphasis on the role of p68 as regards its role in this vital
transduction signal pathway tied to cell proliferation and many
cancer processes.
Results and Discussion
Figure 1A depicts a recently proposed model for the regulation of
alternative splicing of pre-mRNA H-Ras in which hnRNP A1 and
p68 act as inhibitors and SC35 and SRp40 as stimulators of IDX
inclusion [8]. In this model, there are two distinguishing features
driving IDX inclusion: (1) the silencer sequence (rasISS1) down-
stream of IDX that contains a hnRNP A1-binding site; and (2) the
IDX itself also harbors putative sequences that can bind SC35 and
SRp40. Previously, studies using RNA affinity columns containing
either IDX, rasISS1 or the mutant DrasISS1 (see Figure 1B) in
presence of nuclear extract showed that p68, hnRNP H and FUS
bound to IDX and rasISS1, but not to DrasISS1 [8]. Previous in vivo
studies found that RNAi-mediated depletion of p68 increased the
level of endogenous p19 mature mRNA, thereby revealing a role for
p68 RNA helicase as an inhibitor of IDX inclusion [8]. Here we
show that the addition of recombinant p68 to in vitro splicing
reactions (Figure 1C) inhibits splicing of intron D1, (lanes 2, 3 and 4)
and reverts the activation of SRp40 (compare lanes 1 to 2, 3 and 4)
confirming previous results obtained in vivo [8].
RNA folding predictions suggested a stem-loop secondary
structure comprising IDX and rasISS1 sequences, see [8] and
figure1D,that isconservedbetweenhamster,mouse,ratand human
[8]. Interestingly, the addition of the stem-loop RNA sequence to in
vitro splicing reactions enhanced IDX inclusion [8], suggesting that
the reaction can be activated by titrating out inhibitory factors that
recognize this structure. To gain additional insights into the function
of this putative stem-loop structure, we tested whether both
individual IDX and rasISS1 sequences wind together in vitro.
Figure 2A clearly shows that double-stranded (dsRNA) structures
were obtained for IDX and rasISS1 in RNA native gels (see lanes 2–
5), but, very interestingly, not for the DrasISS1 mutant (lanes 6–9),
therebyindicatingthatthe‘‘D’’sequenceisessentialfortheformation
of this dsRNA structure. We next studied whether the IDX-rasISS1-
linked sequence winds and forms a dsRNA in vitro and found that the
IDX-rasISS1sequencewoundinadsRNAstructure(Figure2B,lane
1) that was rapidly reverted to ssRNAin the presence of p68 (lanes 2,
3 and 4). This finding demonstrates that IDX-rasISS1 winds in a
dsRNA structure that is recognized and can be unwound by p68,
pointingtoaroleforthissecondarystructureintheefficientinclusion
of the alternative exon IDX.
The intrinsic nature of the bindingof hnRNPH andFUS/TLSto
IDX and rassISS1 sequences was further studied using binding-shift
assays. GST-fused hnRNP H (GST-H) showed a binding-shift in
native gels in the presence of the rasISS1 sequence, reflecting the
formation of high molecular weight complexes (Figure 2C, left lanes
2,3 and 4),but notinthepresenceofDrasISS1 (Figure 2C,lanes 6, 7
and 8). Since hnRNP H showed no binding-shift with the IDX
sequence (Figure 2C, lanes 10–12) we conclude that its previously
reported association to IDX RNA-affinity [8] columns is due to an
indirect binding or it is a weak interaction that does not survive gel
resolution in binding shift assays. Our studies further demonstrate
that rasISS1 forms a protein-RNA complex in nuclear extract
(Figure 2D, lane 5) that is stabilized and supershifted with anti-
hnRNP H antibodies (lanes 2, 3 and 4), thereby indicating that
hnRNP H is present in this rasISS1 complex and that it is highly
accessible to the antibody. HnRNP H also showed a binding-shift
with the stem-loop IDX-rasISS1 (Figure 2E, lanes 4–6) that was
weakened by the unwinding activity of p68 (see lanes 7–9).
Moreover, crosslinking assays between labeled hnRNP H and
IDX-rasISS1, in the absence or presence of p68 under splicing
conditions in vitro, further confirmed that hnRNP H and IDX-
rasISS1 directly bind (see band at around 50 kDa: Figure 2F, lane 2)
and that this binding is inhibited in the presence of p68 (Figure 2F,
lanes 3–7). Collectively, data from the binding-shift and cross-linking
assays indicate that (1) hnRNP H directly binds to rasISS1 and that
the ‘‘D’’ sequence is required for this binding (Figure 2C, lanes 1–8);
(2) hnRNP H does not directly bind to the IDX sequence and
therefore (Figure 2C), as it was seen to bind in previous IDX-RNA-
affinity column studies [8], we propose that hnRNP H indirectly
binds to IDX via at least one other IDX-bound protein in the
complex. A second explanation is that this binding is weak and does
not survive gel resolution in binding shift assays; (3) hnRNP H was
seen to directly bind to the stem-loop IDX-rasISS1 that involves a
dsRNA stem-loop structure (Figure 2E, lanes 4–9); and (4) p68
regulates hnRNP H-stem-loop binding since p68 reduces this
interaction (Figure 2E and 2F).
Although FUS/TLS was found to bind to IDX and to rasISS1
RNA-affinity columns, this protein showed no binding-shift to any
IDX or rasISS1 sequence (Figure 2C, right). These results indicate
that FUS/TLS should therefore indirectly bind to IDX and rasISS1
through other IDX-bound proteins. Again, a second explanation is
that the binding may be weak and does not survive gel resolution in
gel shift assays. Furthermore, in vitro splicing assays showed that
GST-FUS stimulates intron D1 splicing (Figure 3, lanes 5 and 6),
whereas GST-H did not (lanes 2, 3 and 4).
To better define the roles of hnRNP A1, hnRNP H, FUS/TLS
and p68 in regard to p19 as well as other genes, we analyzed the
effect of depleting these four splicing factors by means of RNAi-
mediated depletion assays to determine how (1) endogenous p19
abundance is affected and (2) the expression of other genes is
regulated. The RNAi-mediated depletion of the four splicing
factors were obtained with specific shRNA oligonucletides
(Figure 4, lanes 2–5) using HeLa cell extracts. Previously, we
have shown that RNAi-mediated depletion of p68 increases p19
mRNA levels [8]. In this study, we found that RNAi-mediated
depletions of FUS/TLS or hnRNP H decreased the p19 protein
level as seen by Western blot quantification (see Figure 4B and C,
respectively); a finding that corroborates with our observation that
the efficient splicing of intron D1 is proportional to the FUS/TLS
level (Figure 3). No change in p19 mRNA abundance was seen
during the RNAi-mediated depletion of hnRNP A1 albeit different
interfering sequences were used (result not shown). As hnRNP A1
was previously reported to downregulate p19 [8], we suggest that
we did not observe this effect for two main reasons: (1) the level of
hnRNP A1 is high and the remaining amount of hnRNP A1 is
enough to maintain the level of p19 mRNA; and (2) other hnRNP
proteins similar to A1, (e.g. A2/B1 and A3 have 57% and 85%
indirect binding to both IDX and rasISS1 sequences has been reported. P68 RNA helicase also showed binding to both IDX and rasISS1 sequences. For
clarity, FUS/TLS- and hnRNP H-RNA bindings are separately showed below on the right. B) Detail of the IDX and rasISS1 sequences. ‘‘D’’ indicates the
region deleted in DrasISS1. C) In vitro splicing reaction of 1N pre-mRNA (containing exon3-D1-IDX-rasISS1) activated with 400 ng of recombinant
SRp40 (lanes 1–4). For lanes 2, 3 and 4, 100, 200 and 400 ng of recombinant p68 was added, respectively. The ‘‘*’’ indicates that
32P-labeled RNA was
used in the assay. D) Proposed secondary structure of the IDX-rasIS1 sequence as previously published [8]. S. Guil et al. also demonstrated that this
structure is conserved in hamster, mouse, rat and humans, and that some silent mutations are compensated by a silent one on the opposite strand
across the four species [8]. The ‘‘D’’ indicates the region deleted in the DrasISS1.
doi:10.1371/journal.pone.0002926.g001
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compensate for lower levels of A1 in regards to regulation of
alternative splicing of H-Ras pre-mRNA.
The RNA derived from the four RNAi-mediated depletion assays
of the splicing factors in HeLa cells were individually incubated in
microarrays containing 19,000 human ESTs. From the results
obtained, we sorted the genes exhibiting modified expression into
five groups showed in Table S1. Group I contains genes whose
expression varies with both the RNAi-mediated depletion of hnRNP
A1 and p68, but not with the RNAi-mediated depletion of FUS/
TLS and hnRNP H. Groups II to V have genes whose expression
only varies with the RNAi-mediated depletion of one of the four
splicing factors, but not with the RNAi-mediated depletion of the
other three. Interestingly, only the ZNF462 gene was found to
increase its expression in the presence of RNAi-mediated depletion
ofhnRNPA1andp68.ZNF462isazincfingerproteinthathasbeen
implicated in agenesis of the corpus callosum [12], a common brain
anomaly. We suggest that ZNF462 and p19 H-Ras could be
coordinately regulated by hnRNP A1 and p68. Microarrays
analyzing the RNAi-mediated depletion of hnRNP A1 showed an
increase and decrease of PDCD4 and BAG4 mRNA levels,
respectively; the proteins of which are thought to have anti-apoptotic
effects [13,14]. For the RNAi-mediated depletion of FUS/TLS, the
microarray data showed a decrease in the tyrosine protein kinase
EGFR mRNA level; EGFR gene mutations have been observed in
lung cancers [15]. Moreover, RNAi-mediated depletion of hnRNP
H also produced a significant decrease in the ARAF, CABLES and
PCBP4 mRNA levels. All three proteins are known to be involved in
cell proliferation [16,17,18]. Interestingly, the knockdown of p68
downregulated TOB2that isknowntobeanendogenousactivatorof
pro-proliferative pathways [19].
Since the SR proteins SC35 and SRp40 are known to enhance
p19 H-Ras alternative splicing [8], we also analyzed whether the
RNAi-mediated depletion of hnRNP A1, FUS/TLS, hnRNP H
and p68 affect SR proteins mRNA levels. Selected results of these
studies are provided in Table 1. Note that other SR proteins that
Figure 2. P68 RNA helicase unwinds IDX-rasISS1 in vitro. A) Winding activity assay between IDX and rasISS1 RNAs. The ‘‘*’’ indicates that
32P-
labeled RNA was used. The other RNAs were added unlabeled (cold). All lanes contain 18 ng IDX. Lane 1: no additional RNA; lanes 2, 3, 4 and 5: 1, 10,
50 and 100 ng cold rasISS1 RNA, respectively; lanes 6, 7, 8 and 9: 1, 10, 50 and 100 ng cold DrasISS1, respectively. dsRNA: double-stranded RNA;
ssRNA: single-stranded RNA. Samples were run on a 8% (w/v) native polyacrylamide gel. B) Winding activity assay of the IDX-rasISS1 RNA (1 pmol) in
the absence (lane 1) or presence of increasing amounts of p68 (100, 200 and 400 ng in lanes 2, 3 and 4, respectively). P68 RNA helicase was added
after winding assays followed by 1 h at 37uC. Samples were run on a 8% (w/v) native polyacrylamide gel. C) On the left, binding-shift assay of labeled
rasISS1, DrasISS1 and IDX RNAs (1 pmol each) with increasing amounts of recombinant GST-fused hnRNP H (GST-H). Lanes 1, 5 and 9 did not contain
GST-H; lanes 2–4, 6–8 and 10–12 contained 100, 200 and 400 ng, respectively, of recombinant GST-H. HMW (high molecular weight). On the right,
similar experiment with GST-FUS is showed. D) Binding-shift assay of labeled rasISS1 RNA in nuclear extract (lanes 2–8) or without extract (in Roeder D
buffer, lanes 9–14). Lane 1 did not contain nuclear extract. To obtain supershift complexes, 0.5, 1 and 2 ml anti-hnRNP H serum (lanes 2, 3 and 4,
respectively) and 0.5, 1 and 2 ml anti-FUS (lanes 6, 7 and 8, respectively) were added to the reaction. Lane 5 contained nuclear extract only. Lanes 9–
10, 11–12 and 13–14 contain 100, 200 and 400 ng of recombinant GST-H and GST-FUS, respectively. Samples were run on a 6% (w/v) native
polyacrylamide native gel. HMW (high molecular weight). E) Pre-winded
32P-IDX-rasISS1 RNA was incubated with 0.6 and 1.2 mg recombinant p68
(lanes 2 and 3, respectively), with 160, 320 and 640 ng recombinant hnRNP H (lanes 4, 5 and 6, respectively). Lanes 7, 8 and 9 contained 160, 320 and
640 ng recombinant hnRNP H, respectively plus 1.2 mg of recombinant p68. Samples were run on a 6% (w/v) native polyacrylamide gel. F)
Crosslinking assay between hnRNP H (640 ng) and
32P-IDX-rasISS1 RNA (1 pmol) (lanes 2–7). Lane 1 did not contain hnRNP H. Lanes 3–7 contained
100, 200, 400, 800 and 1200 ng p68, respectively. Samples were run on a 10% SDS-polyacrylamide protein gel and autoradiographed.
doi:10.1371/journal.pone.0002926.g002
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levels of SC35 and SRp40 showed no variation with any of the
RNAi-mediated depletions here studied; however, interestingly,
SRp20 and SFRS14 mRNAs were downregulated with RNAi-
mediated depletion of p68. Although SC35 was not regulated by
any of these RNAi-mediated depletions, a SR protein that
specifically binds to SC35, namely SFRS2IP, was upregulated by
RNAi-mediated depletion of hnRNP A1, and to a lesser extent by
the RNAi-mediated depletions of FUS/TLS and hnRNP H.
These findings suggest that these three proteins may regulate a
feedback loop involving SC35 via SFRS2IP.
Using RNAi-mediated depletion assays, we next analyzed how
the RNAi-mediated depletions of p68, hnRNP A1, hnRNP H and
FUS/TLS affect SC35 localization inside the cell. We found that
only RNAi-mediated depletion of p68 alters SC35 localization
(Figure 5A, panel -p68) by increasing SC35 levels outside of the
interchromatin granule cluster (IGC) in a diffuse nuclear pattern.
This suggests that RNAi-mediated depletion of p68 can induce
SC35 to be localized similar to that seen in actively transcribing
cells where both splicing and transcription factors display a highly
dynamic localization within the nucleus and may be recruited
from speckles to the position of active transcription [20].
Moreover, despite not affecting SC35 expression, the downregu-
lation of p68 may increase the level of SC35 protein available for
the splicing machinery, such as for p19 H-Ras alternative splicing.
Whether p68 modifies the dynamic localization of other
speckles was also studied in RNAi-mediated depletion assays.
RNAi-mediated depletion of p68 was observed not to affect the
localization of B’’ (U2snRNP), Coilin and SMN speckles; however,
when p68 was knocked down, SMN bodies were more susceptive
to anti-SMN antibodies (Figure 5B, compare SMN panels).
Finally, RNAi-mediated depletion of p68 did not stimulate cell
apoptosis (Figure 5B PARP panels and 5C), nor did it activate the
dsRNA-activated protein kinase PKR, since eIF2-a was not
hyperphosphorylated (not shown).
Collectively, we have found that p68 regulates p19 H-Ras splicing
by (1) affecting the dsRNA structure of the stem-loop IDX-rasISS1
(Figure 2B), (2) disrupting binding of hnRNP H to the stem-loop
IDX-rasISS1 (Figure 2E) and (3) may increase the level of SC35
protein available for the splicing machinery, such as for p19 H-Ras
alternative splicing (Figure 5A). Moreover, (4) knockdown of either
hnRNP A1,FUS/TLS or hnRNPH (Table 1) led to upregulation of
SFRS2IP, a SC35-binding protein. Currently, studies are underway
to decipher whether SFRS2IP exerts an effect on IDX inclusion.
Finally, (5) although FUS/TLS showed no direct binding to the
stem-loop IDX-rasISS1 (Figure 2 C, right), assays have indicated
that FUS stimulated IDX inclusion (Figure 3 and Figure 4B). (6)
Now, we know that hnRNP H binds to the stem-loop IDX ras-ISS1
(Figure 2), but so far our in vitro splicing studies have not thrown light
on its action as regards IDX inclusion. However, as the p68 (an
inhibitorofIDXinclusion)weakened hnRNPHbindingto the stem-
loop (Figure 2), it is likely that hnRNP H is necessary to stimulate
IDX inclusion. This latter reasoning agrees with the in vivo
downregulation of p19 by hnRNP H knock-down (Figure 4 C).
There are to date only a few studies reporting on the
synchronized action of all the splicing factors studied here.
Interestingly, RNA helicase A was also found to associate with
hnRNP proteins including hnRNP H [21]. Additionally, RNAi-
mediated depletion studies revealed that by suppressing the
expression of RNA helicase A, the nuclear distribution of hnRNP
C was altered [21]. Van Herreweghe et al. recently showed that a
fraction of HeLa 7SK snRNA specifically interacts with RNA
helicase A and heterogeneous nuclear ribonucleoprotein A1 [22].
Moreover, p68 was found to shuttle in and out of SC35 domains,
forming fibers and granules in a cell-cycle dependent manner [23].
Functional analysis demonstrated that SC35 and TASR, a FUS-
associated protein with SR repeats, have antagonistic effects on
adenovirus E1A pre-mRNA splicing and abrogate the influence of
FUS on this splicing. Interestingly, protein-protein assays have
revealed that FUS is also associated with helicases [24]. The
hnRNP A1 and SR proteins have also been reported to have
antagonistic functions in splicing processes [8,25,26,27,28]. In
addition, a recent NMR study showed the competition between
proteins SC35, SRp40 and heterogeneous nuclear ribonucleopro-
tein A1 at the HIV-1 Tat exon 2 splicing site [26].
All the factors implicated so far in the regulation of the
alternative splicing of H-Ras seem to also be involved in regulating
many other splicing processes and to act in concert. An
observation that serves to emphasize that the alternative splicing
model studied here is highly helpful in advancing our understand-
ing of the interactions of all these splicing factors. This enhanced
understanding will better enable us to define cis-element sequences
and trans-acting factors as well as to determine their interactions in
generating future models for other exon splicing processes. The
number of cis-element sequences and trans-acting factors implicat-
Figure 3. FUS stimulates IDX inclusion. Lane 1: In vitro splicing
reaction of
32P-1 N pre-mRNA (containing exon3-D1-IDX-rasISS1); lanes
2, 3 and 4: 65, 130 and 260 ng recombinant GST-H,; lanes 5 and 6: 90
and 180 ng recombinant GST-FUS. Samples were run on a 10% urea
denaturing polyacrylamide gel.
doi:10.1371/journal.pone.0002926.g003
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secondary structures, indicates how complex and fine-tuned the
regulation of this gene is. The pivotal role of p68 in the regulation
of such an important signal transduction pathway further
underlines the need to better understand winding/unwinding
activities in cancer processes.
Materials and Methods
Antibodies
The following antibodies were generous gifts: anti-p68 RNA
helicase PAb204 (Dr. F. Fuller-Pace); anti-hnRNP A1 4B10 (Dr. G.
Dreyfuss);anti-hnRNPHAN113(Dr.D.Black);anti-FUS/TLS474
(Dr. F. Moreau-Gachelin); anti-SMN 2B1 (Dr. G. Dreyfuss); and
anti-p19 H-Ras [7]. Anti-SC35 (BD Pharmingen), anti-B’’ (Euro-
Diagnostica), anti-Coilin C1862 (Sigma) and anti-PARP (BD
Pharmingen) were purchased from commercial suppliers.
Figure 4. RNAi-mediated depletion of FUS and hnRNP H downregulates p19 H-Ras expression. A) Western blot on HeLa extracts from
cells specifically depleted by means of RNAi-mediated depletion of p68 (lane 2), hnRNP A1 (lane 3), FUS/TLS (lane 4) and hnRNP H (lane 5). Lanes 1:
HeLa cells transfected with empty pSuper vector (negative control). Antibodies against actine or GAPDH were used as loading controls. B) Western
blot on extracts similar as in (A), lane 4, with RNAi-mediated depletion of FUS/TLS (lanes RNAi FUS) as compared to cells transfected with empty
vector, lanes (-). Cells were transfected with 6 mgo r4mg of the pSuper plasmids. Samples were run on 12.5% SDS denaturing polyacrylamide gels.
Blots were incubated with anti-p19 and anti-FUS antibodies. Anti-GAPDH was used in all lanes as internal loading control and also as a fixed value of 1
to which all calculations for each lane were standardized. Blots subjected to chemiluminescence (peroxidase-luminol) and then quantified with the
imaging software Multi Gauge V3.0 (Fujifilm) using LAS 3000 apparatus (Fujifilm). The RNAi-mediated depletion of FUS/TLS induced a drop on the
protein abundance of 52–64% on FUS and 27–35% on p19. C) Western blot on extracts with siRNA-mediated depletion of hnRNP H with a siRNA to
hnRNP H (Santa Cruz Biotechnology, sc-35579). Lane (-) contains the siRNA-B control (Santa Cruz Biotechnology, sc-44230). The siRNA depletion of
hnRNP H induced a drop on the protein abundance of 50% on both hnRNP H and p19 proteins.
doi:10.1371/journal.pone.0002926.g004
Table 1. Log2 is the log2 value of the fold change measuring
the effect of the RNAi on the ESTs expresio ´na sc o m p a r e dw i t h
the negative control performed with the empty pSuper vector.
SR proteins expression affected by RNAi of hnRNP A1, FUS/TLS,
hnRNP H and p68 RNA helicase
A1 FUS H P68 SR protein symbol
Log2
0.00 20.14 0.00 20.82 SFRS3 (SRp20)
20.40 20.07 20.32 0.29 SFRS2 (SC35)
20.36 0.00 20.04 20.04 SFRS5 (SRp40)
0.25 0.08 20.38 20.88 SFRS14
1.44 0.85 0.91 0.51 SFRS2IP
Log2 higher than 1 were taken as significant values.
doi:10.1371/journal.pone.0002926.t001
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transfection assays and RNA analysis, gel shift assays, and
SR protein complementation and western blots
Details of all constructs and approaches were previously
reported [7,8].
Native RNA gels and winding/unwinding assays
32P-labeled (1 pmol; 20,000 cpms) RNAs (either IDX plus
rasISS1 or IDX-rasiSS1) were placed to wind in Roeder D buffer
containing 1 mM ATP and 1.5 mM MgCl2 for 5 min at 90uC
followed by 1 h at 37uC. P68 RNA helicase and/or hnRNP H
were added after winding assays followed by 1 h at 37uC. The
reactions were stopped by the addition of 50% glycerol, 2% SDS,
20 mM EDTA and 0.025% bromophenol blue and xylene cyanol
(25% of the total reaction volume). Samples were analyzed on 8%
(w/v) native acrylamide gels in 1x TBE buffer.
RNAi
The deoxyoligonucleotides used to construct pSuper are as
follows:
Figure 5. Downregulation of p68 RNA helicase alters the dynamic localization of the SC35 splicing factor. A) Indirect
immunofluorescence detection of HeLa cells containing the pSuper-RNAi-p68 RNA helicase vector (-p68); pSuper-RNAi-A1 vector (-A1); pSuper-
RNAi-H vector (-H); pSuper-RNAi-FUS vector (-FUS). As negative controls, cells were transfected with empty pSuper (-). Anti-SC35 primary antibody
diluted 1/600 (mouse) and secondary anti-mouse Alexa FluorH 633 F(ab’)2-labeled antibody . B) Indirect immunofluorescence detection of HeLa cells
containing the pSuper-RNAi-p68 RNA helicase vector (-p68) or pSuper empty vector (-) incubated with anti-B’’ (1/20, mouse), anti-Coilin (1/100,
rabbit), anti-SMN (1/1000, mouse) and FITC-labelled anti-PARP (1/100, mouse). Primary mouse and rabbit antibodies were incubated with secondary
anti-mouse Alexa FluorH 633 or 488, respectively, F(ab’)2-labeled antibody. C) Flow cytometric experiments estimating apoptosis levels in HeLa cells
transfected either with empty pSuper or pSuper-RNAi-p68 RNA helicase vectors, and stained with annexin V-FITC (Annexin LOG) and propidium
iodide (IP LOG). R3 represents % of viable cells and R1+R2 % of dead plus apoptotic cells.
doi:10.1371/journal.pone.0002926.g005
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TAttcaagagaTACTCATGGAGGATTGATCtttttggaaa;
pSUPER-FUS605rev, agcttttccaaaaaGATCAATCCTCCAT-
GAGTAtctcttgaaTACTCATGGAGGATTGATCggg;
pSUPER-H323for, gatccccGTATTCAAGTCAAACAACGtt-
caagagaCGTTGTTTGACTTGAATACtttttggaaa;
pSUPER-H323rev, agcttttccaaaaaGTATTCAAGTCAAACA-
ACGtctcttgaaCGTTGTTTGACTTGAATACggg;
pSUPER-A1382for, gatccccGATTCTCAAAGACCAGGTG-
ttcaagagaCACCTGGTCTTTGAGAATCtttttggaaa;
pSUPER-A1382rev, agcttttccaaaaaGATTCTCAAAGACCA-
GGTGtctcttgaaCACCTGGTCTTTGAGAATCggg.
pSuper-p68 RNA helicase vector and RNAi-mediated depletion
assays were performed as previously described [8].
Recombinant proteins
Recombinant plasmids were generous gifts from the following
researchers: p68 was obtained from the pET30a vector (Dr. Z-R.
Liu); GST-H from pGEX-H (Dr. J. Wilusz); GST-FUS from
pGEX-FUS (Dr. F. Moreau-Gachelin); and hnRNP H from pET
15-B (Dr. D. Black). Recombinant proteins were obtained and
purified as described by the manufacturers of the pGEX and pET
vectors from AmershamBiosciences and Clontech, respectively.
Direct and indirect immunofluorescence
These assays were performed as detailed elsewhere [7].
Apoptosis assays
HeLa cells were transfected either with the pSuper-p68 RNAi
or empty pSuper plasmids. Apoptotic cells were detected by flow
cytometry using the Annexin V-FITC Apoptosis Detection Kit
(Sigma) according to the manufacturer’s instructions. Flow
cytometric experiments were carried out using an Epics XL flow
cytometer (Coulter Corporation, Miami, Florida, USA). Excitation
of the samples was achieved by using an air-cooled argon-ion laser
set at 488 nm and 15 mW power with other parameters at
standard configuration. Forward scatter (FSC), side scatter (SSC),
green (525 nm) fluorescence for Annexin-FITC-conjugated anti-
body and red (675 nm) fluorescence for PI were used. Green
fluorescence was measured with a 550 nm dichroic-long filter and
525 nm bandpass filter. Red fluorescence was collected with a
645 nm dichroic-long filter and a 675 nm bandpass filter. Optical
alignment was based on an optimized signal from 10 nm
fluorescent beads (Immunocheck, Epics Division).
ESTs microarrays incubation and bioinformatics analysis
cDNA samples from HeLa cells transfected with either pSuper-68
RNAi vector, pSuper-A1 RNAi vector, pSuper-H RNAi vector or
pSuper-FUS RNAi vector were compared against control samples
transfected with empty vector pSuper. Two-color hybridizations
were performed in triplicate. A total of 12 human 19,008 different
ESTs (ss-H19k4.1) from Microarray Centre (Toronto) were assayed.
Briefly, 500 ng of total RNA from each sample were amplified by
Oligo-dT-T7 reverse transcription and labeled by in vitro transcrip-
tion with T7 RNA polymerase in the presence of Cy5-CTP or Cy3
CTP using the Low Input RNA labeling kit (Agilent) and cleaned
using RNAeasy columns (Qiagen). After fragmentation, 750 ng of
labeled cRNA from each of two samples were co-hybridized in situ in
hybridization buffer (Agilent) for 18 h at 60uC and washed for
10 min in 6X SSC+0.005% Triton X-102 at room temperature and
5 min in 0.1X SSC+0.005% Triton X-102 at 4uC, followed by
drying by centrifugation for 5 min at 1000 rpm. Images were
generated on an Agilent confocal microarray scanner at 10 mm
resolution and quantified using GenePix 6.0. Spots with signal
intensities twice above the local background that were also not
saturated or flagged by GenePix were considered as reliable and
weregivenaweight of 1fornormalizationpurposes,whereasthe rest
were given weights of 0.01. Extracted intensities were subtracted
from the local background and the log2 ratios were normalized in an
intensity-dependent fashion by the global lowest method with a span
parameter of 0.3. Normalized log2 ratios were scaled between arrays
to allow better comparison of data. Raw data were processed using
MMARGE (Lozano et al, unpublished), a web implementation
(http://nin.crg.es/microarray.html) of Limma [29] and a micro-
array analysis library developed within the Bioconductor project in
the R statistical environment [30]. For determining significant hits,
the empirical Bayes statistic B was used. To compare the empty
vector and RNAi vectors, a contrast test was applied taking the
normalized log2 ratios of the three microarray hybridizations of each
type as replicates against the same common control reference using
BANAL, a web-based interface also running on Limma.
Crosslinking assays
32P-labeled (1 pmol, 20,000 cpms) IDX-rasISS1 RNA was
allowed to bind to 640 ng recombinant hnRNP H in binding
buffer (1 mM ATP, 1.7 mM MgCl2 and 0.1 mM heparin in
16Roeder D buffer). Binding reactions were also performed in the
presence of increasing concentrations of recombinant p68 (100–
1200 ng protein). All tubes were incubated for 30 min at 30uC,
UV-crosslinked with a Stratalinker 1800 (Stratagene) at 1.2 J for
30 s and then treated with RNAse T1 for 1 h at 37uC. Proteins
were analyzed on 8% SDS-PAGE gels as previously described [8]
and then autoradiographed.
Supporting Information
Table S1 Table S1 is loaded as online supporting information.
The accession number for the microarray data is GSE12058 in
http://www.ncbi.nlm.nih.gov/geo.
Found at: doi:10.1371/journal.pone.0002926.s001 (0.14 MB
DOC)
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